Radiation Oncology Department and Breast Center, Henri Mondor Breast Unit, University Hospital Henri Mondor, Creteil, FranceBreast neoplasms; Gynecologic cancers; Hematologic malignancies; Prostate cancer; Rare tumors; Radiation oncology
Chairman of the Department of Radiation Oncology, Head of the Henri Mondor Breast Unit, University Hospital Henri Mondor, France
Professor in Radiation Oncology, University of Paris XII
Shanghai University of Medicine & Health Sciences, Shanghai, ChinaNuclear medicine; Molecular imaging; Molecular probes; Tumor radiomics; Biomedical engineering
Chairman of the Ninth Committee of the Nuclear Medicine Society of the Chinese Medical Association
Dean of Shanghai Health Medical College
Director of Shanghai Key Laboratory of Molecular Imaging, Director of Institute of Clinical Nuclear Medicine, Dean of the School of Nuclear Medicine, Shanghai Jiao Tong University
Shandong Cancer Hospital, Jinan, ChinaChemoradiotherapy; Immunotherapy; Non-small cell lung cancer; Esophageal squamous cell carcinoma
Academician of the Chinese Academy of Engineering
Honorary President of Shandong Academy of Medical Sciences
President of Shandong Cancer Hospital
Department of Radiation Oncology, Peking University Third Hospital, Beijing, ChinaComprehensive treatment of head and neck tumors; Lung cancer; Esophageal cancer; Prostate cancer; Rectal cancer; Vertebral body tumors; Soft tissue tumors; Minimally invasive brachytherapy for metastatic cancer
Chairman of the Radiation Oncology Branch of the Chinese Medical Association, China
Director of the Department of Radiation Oncology, Peking University Third Hospital, China
President of the Lanzhou Branch of Wuwei Cancer Hospital, Gansu Province, China
Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaMulti-modal imaging technologies; SPECT/CT; PET/CT; PET/MR; Long-wheelbase PET systems; Molecular probes
Director of the Department of Nuclear Medicine, Zhongshan Hospital Affiliated with Fudan University, China
Director of the Institute of Nuclear Medicine at Fudan University, China
Deputy Director of Shanghai Institute of Imaging Medicine, China
Department of Radiation and Medical Oncology, 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaRadiotherapy; Lung cancer; Esophageal cancer; Radiomics; Image-guided radiotherapy technology
Vice President of the First Affiliated Hospital of Wenzhou Medical University;
Council Member of the Chinese Society of Clinical Oncology (CSCO);
Vice Chairman of the Precision Radiotherapy Technology Branch of the Chinese Society of Biomedical Engineering;
Executive Committee Member of the Professional Committee for Tumor Radiation Protection of the China Anti-Cancer Association;
Chairman of Radiation Oncology Branch of Zhejiang Medical Association;
Director of Zhejiang Engineering Research Center for Innovation and Application of Intelligent Radiotherapy Technology.
Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, SwitzerlandPET imaging; Artificial intelligence; Quantitative imaging; Nuclear medicine; Instrumentation; Medical physics
Hossein Arabi received the Ph.D. degree in medical physics from the University of Geneva, in 2016. From 2016 to 2021, he was a Postdoctoral Fellow in medical image processing and artificial intelligence with the University of Geneva, where he was a Senior Research Assistant, in 2021. He is currently a Senior Research Assistant with the Department of Nuclear Medicine, Geneva University Hospital.
Department of Radiation and Medical Oncology, 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaNew technologies in radiation oncology research; Artificial intelligence; Radiomics
Ph.D. Candidate Supervisor, Professor-level Senior Engineer, Vice Dean of the School of Basic Medical Sciences, Wenzhou Medical University; Director (concurrently) of the Functional Experiment Teaching Center; Vice President (concurrently) of the First School of Clinical Medicine (School of Information and Engineering) and the First Affiliated Hospital; Vice President of Asia-Pacific Federation of Organizations for Medical Physics.
Department of Radiation Therapy, the First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaClinical radiation oncology therapeutics; Radiation biology
Chief Physician (Level 2), Professor, Doctoral Supervisor
Director, Department of Radiation Oncology, Jiangsu Provincial People’s Hospital
Academic Leader, Key Discipline of Radiation Oncology, Jiangsu Provincial Health Commission
Vice Chair, 11th Committee of Radiation Oncology, Chinese Medical Association
Chair, Breast Cancer Working Group, Radiation Oncology Branch, Chinese Medical Association
Vice Chair, Esophageal Cancer Working Group, Radiation Oncology Branch, Chinese Medical Association
Vice Chair, Esophageal Cancer Working Group, Radiation Oncology Branch, Chinese Medical Doctor Association
Vice Chair, Esophageal Cancer Working Group, Radiation Oncology Branch, Chinese Anti-Cancer Association
UT Southwestern Medical Center, Dallas, United StatesRo-radiation oncology; Neurological surgery
Professor and Chair of Radiation Oncology
Professor of Neurosurgery
Effie Marie Cain Distinguished Chair in Cancer Therapy Research
National Principal Investigator of Radiation Therapy Oncology Group (RTOG) trials
Department of Medical Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, ChinaRadiation oncology; Brachytherapy; Molecular biology oncology
President, Zhongshan Hospital Affiliated to Dalian University
Dean, Zhongshan Clinical College
Head, Leading Group for Standardized Residency Training
Chair, Expert Committee for Standardized Residency Training
Academic Leader, Key Clinical Specialty of Oncology in Liaoning Province
Director, Dalian Municipal-Level Key Discipline & Dalian Medical Soft Power Oncology Base
Department of Nuclear Medicine, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaThyroid disease; Radionuclide therapy for bone metastases; Nuclear medicine diagnosis; SPECT; PET/CT
Director, Department of Nuclear Medicine, Xijing Hospital
Professor, Chief Physician, Doctoral Supervisor
Expert Receiving Special Government Allowance from the State Council
Fellow, American College of Nuclear Medicine (ACNM)
Chairman, Nuclear Medicine Branch, Chinese Medical Association
Vice President, Nuclear Medicine Physician Branch, Chinese Medical Doctor Association
Chairman, Shaanxi Provincial Society of Nuclear Medicine and Molecular Imaging
Department of Nuclear Medicine, Peking University Cancer Hospital, Beijing, ChinaNuclear medicine; Radiopharmaceuticals; Radio-probe; Chemoradiotherapy
Director, Department of Nuclear Medicine, Peking University Cancer Hospital
Deputy Director, Department of Nuclear Medicine, Peking University Health Science Center
Director, NMPA Key Laboratory for Radiopharmaceutical Research and Evaluation
Director, Beijing Municipal Center for Nuclear Medicine Quality Control & Improvement
Chairperson, Society of Radiopharmaceuticals, Chinese Nuclear Society
Chair-Elect, Nuclear Medicine Branch, Beijing Medical Association
Department of Radiology, University of Pennsylvania, Philadelphia, United StatesComputed tomography; Imaging; Medical imaging; Neuroimaging; Neurodegenerative diseases; Magnetic resonance; Surgery; Neuroscience; Density functional theory; Neonatology
Abass Alavi is an Iranian-American physician-scientist specializing in the field of molecular imaging, most notably in the imaging modality of positron emission tomography (PET). In August 1976, he was part of the team that performed the first human PET studies of the brain and whole body using the radiotracer [18F]Fluorodeoxyglucose (FDG). Alavi holds the position of Professor of Radiology and Neurology, as well as Director of Research Education in the Department of Radiology at the University of Pennsylvania. Over a career spanning five decades, he has amassed over 2,300 publications and 60,000 citations, earning an h-index of 125 and placing his publication record in the top percentile of scientists.
Department of Physics, University of Pavia, Pavia, ItalyBNCT; Nuclear physics
Saverio Altieri played a major role in the Taormina project for the treatment by BNCT of diffuse hepatic metastases on explanted liver. He worked on the assessment of a technique for the boron concentration measurement (alpha spectrometry) and imaging (neutron autoradiography). Coordinator of Pavia University BNCT group in collaboration with national and international Institutions; main efforts devoted to the collaboration with the CNAO for the realization of an AB-BNCT facility.
Department of Medical Physics and Biomedical Engineering, University College London, London, United KingdomProton therapy; Ion beam therapy; FLASH radiotherapy; Radiotherapy physics; BNCT
Richard is Hon. Associate Professor of Proton Therapy at UCL and former Lead for Proton Therapy Physics at UCL Hospitals NHS Foundation Trust.
Richard trained as a clinical scientist at the Royal Free Hospital in London before working as a clinical radiotherapy physicist for several years in the NHS and for Cancer Care Ontario in Canada. He also worked at the Gray Laboratory Cancer Research Trust managing and using the ion microbeam facility for the study of radiation bystander effects in vitro.
Department of Radiation Therapy, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China.Breast tumors; Precise radiotherapy; Itensity-modulated radiotherapy; Stereotactic radiotherapy; TOMO
Professor and Chief Physician, Graduate Supervisor
Deputy Director of Radiation Oncology Department, Cancer Hospital, Chinese Academy of Medical Sciences
Key Member of Ministry of Education Innovation Team
Vice Chair of Youth Group, Radiation Oncology Society, Chinese Medical Association
Vice Chair of Youth Committee, Radiotherapy Professional Committee, Chinese Anti-Cancer Association
Vice Chair of Lung Cancer Group, Radiotherapy Committee, Chinese Medical Doctor Association
Council Member of CSCO
Member of NSCLC/SCLC/Radiotherapy Committees, CSCO
Committee Member of Radiation Oncology Society, Beijing Medical Association
Radiation Oncology Center, Fondazione Poliambulanza, Brescia, ItalyStereotactic body radiation therapy (SBRT); Brain radiosurgery; Innovative radiation technology (IRT); Pancreatic cancer; Liver tumors
Health Manager, Zaffiro Nord SRL, Brescia office
Radiation Oncologist, Poliambulanza Foundation Multispecialty Hospital Institute
1. Institut Pluridisciplinaire Hubert Curien, Université de Strasbourg, Strasbourg, France;
2. UMR7178, CNRS, Strasbourg, FranceMolecular imaging; Positron emission tomography; Instrumentation; Image reconstruction; Preclinical studies
David Brasse received the Ph.D. degree in physics, Paris V University, Paris, France, in 1999, with a focus on PET imaging using SPECT systems. He has been the Research Director, Level 2 of CNRS, IPHC, UMR 7178, since 2012. He has authored two book chapters, more than 70 peer-reviewed articles, and two patents. His research interests include micro-dosimetry, proton therapy, PET imaging and SPECT systems, radiation therapy, and the interface between physics, biology, and medicine—preclinical instrumentation. Dr. Brasse was awarded the Scientific Excellence Award from CNRS in 2018.
Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Rome, ItalyProstate cancer (and genitourinary in general); Upper gastrointestinal malignancies (esophageal, gastric, pancreatic, liver, biliar tract cancer); Rectal cancer; Non-oncological applications of radiotherapy; Non oncological ablative radiotherapy for refractory arrhythmias; Palliative radiotherapy; Ablative radiotherapy (by SBRT); MR guided radiotherapy (MRgRT)
Department of Physics, The University of Texas at Arlington, Arlington, United StatesNanomaterials; Nanomedicine; Cancer nanotechnology
Professor of Physics, The University of Texas at Arlington.
Education:
Ph. D. in Chemistry, 1992, Peking University, Beijing, China
MS in Crystallography, 1988, Central South University, Changsha, China
BS in Mineral Chemistry, 1985, College of Earth Science, Jilin University, Changchun, China
Awards:
Distinguished young scientist award by the Chinese Academy of Sciences, 1997
Honor award for the distinguished achievement in Science & Technology by State Education Commission of China, 1995
Honor award for the achievement in Science & Technology by Peking University,1994
Research Excellent Award, University of Texas at Arlington, 2008, 2009, 2010
Prof. Dr. Al. Trestioreanu Oncology Discipline, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaRadiotherapy; Brachytherapy; Head and neck cancer; Colorectal cancer; Uterine cancer
Department of Medical Sciences, RMIT University, Melbourne, AustraliaRadiotherapy physics; Dosimetry, radiobiology and imaging in radiotherapy; Applications of nanoparticles and quantum dots in radiology and radiotherapy; Radiation dose enhancement by metallic nanoparticles; Image contrast enhancement by metallic nanoaprticles
Physics Department, University of Milan, Milan, ItalyRadiation detection; Gamma spectrometry; Radiation physics; Neutron activation analysis; Radiation protection; Nuclear physics; Experimental physics; Medical physics; Dosimetry; Nuclear reactions; Radiation dosimetry; Radiation; Radioactivity
Centre for Advanced Imaging, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, AustraliaRadiotherapy; Cyclotron; PET; PET-MRI
Dr. Arif Gulzar has obtained doctorate degree in Material Science and Engineering. His research focuses on cyclotron operation for the production of novel radioisotopes such as 68Ga etc and chelator free radiolabelling of nanoparticles for cancer theragnostic.
Department of Radiation Oncology, UMass Chan Medical School and UMass Memorial Medical Center, Worcester, United StatesRadiation oncology; Thoracic oncology; Immunotherapy; SBRT
Gemelli-INTERACTS, Università Cattolica del Sacro Cuore, Rome, ItalyBrachytherapy; Interventional oncology
Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, IndiaMedicinal and pharmaceutical chemistry; Organic synthesis; Synthetic organic chemistry; Heterocyclic chemistry; Synthetic medicinal chemistry; Total synthesis; Heterocyclic compounds synthesis; Pharmaceutical chemistry; Natural product synthesis; Drug discovery; Drug synthesis; Nuclear magnetic resonance; Bioorganic chemistry; Microwave assisted organic synthesis; Click chemistry; Small molecule Drug discovery; New drug discovery; Microwave synthesis; Anticancer studies; Anti-Cancer drug design and discovery; Synthesis of medicinal compounds; Isoxazoles; Molecular recognition; Triazines; In Vitro screening; Pyrazolones; IC50; Benzimidazoles; Toxicology; Antibacterials; Docking studies; Antibacterial activity; Materials chemistry; Synthesis work; Multistep synthesis; Molecular docking; Green chemistry Technology; Asymmetric catalysis
Department of Nuclear Medicine, University Hospital of Tübingen, Tübingen, GermanyPET/CT & PET/MR (oncology, neurology, inflammation); SPECT/CT (oncology, cardiology, neurology, inflammation); Thyroid special outpatient clinic; Radioiodine therapy in thyroid disease; Peptide radioligand therapy for prostate cancer (Lu-177 PSMA); Peptide radioreceptor therapy in NET and meningiomas; Local liver therapy (SIRT); Radioligand therapy (mIBG, Zevalin)
Department of Radiation Oncology, Sichuan Cancer Hospital and Research Institute, Chengdu, Sichuan, ChinaPrecision radiation therapy for tumors; Nuclear medicine; Multidisciplinary therapies combined with chemotherapy; Molecular targeting therapy; Immunotherapy; Nutritional therapy
Department of Radiotherapy, Institute Bergonie, Bergonie, FranceElderly cancer patients; Cardiac toxicities; Cervix carcinomas; Head and neck oncology; Pharmacological biomodulation and radiation; Basic science with a particular scope in tumoral stem cells and invasion/migration
1. Cancer Research UK Scotland Institute, Garscube Estate, Glasgow, United Kingdom
2. School of Cancer Sciences, University of Glasgow; Glasgow, United KingdomMolecular Imaging; Nuclear Medicine; Oncologic Imaging; PET; Preclinical Imaging; Novel Radiotracers; Translational Imaging
Department of Urology, Prostate Cancer Center, Kanagawa, JapanProstate brachytherapy
Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, United StatesExternal beam radiation; Image-guided and intensity-modulated radiation; Prostate brachytherapy (seed implants); Stereotactic body radiation therapy; Cancers of the prostate, bladder and urinary tract, and testicular cancer
1. Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy
2. Istituto di Radiologia, Università Cattolica del Sacro Cuore, Rome, ItalyRadiation therapy; Brachytherapy; Therapeutic procedure
1. Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
2. Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, SwedenNuclear medicine; Radiochemistry; Radiopharmaceuticals; Positron emission tomography; Oncology; Fibrosis; Inflammation; Diabetes
Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan, ChinaChest tumors; Radiation therapy; Brachytherapy; Preoperative and postoperative adjuvant therapy; Multidisciplinary comprehensive therapy; Clinical and scientific research
Division of Radiological Sciences, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, United StatesAlzheimer’s disease; Parkinson's disease; Central nervous disorders; Postmortem biomarker validation and characterization; In vivo positron emission tomography; In vitro quantitative autoradiography
Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, China.Personalized therapy; Carbon-ion radiotherapy; Adaptive split-course SBRT and/or hypofractionation radiotherapy based on systemic therapy (3S); Spatially fractionated radiation
1. Department of Nuclear Medicine and Molecular Imaging, Radiological Sciences Division, Singapore General Hospital, Singapore;
2. Duke-NUS Medical School, SingaporeRadiopharmaceuticals and radiochemistry; Radiosynthesis and radiolabeling; Radioisotope production and application; Radiotracer development for nuclear imaging; Theranostics of radiopharmaceuticals; Radiation safety
Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, ChinaTumor minimally invasive diagnosis and treatment; 3D printing template guides precise needle biopsy of pulmonary nodules; Esophageal seed stent implantation; Radioactive seed implantation; Microwave ablation; Percutaneous vertebroplasty
Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, ChinaTarget detection; Tracking and recognition technology; Multimodal image registration and fusion technology; Real scene 3D reconstruction technology; Biomedical imaging; Image processing and recognition technology
Radiation Oncology Department, University Hospital of Schleswig-Holstein, Lübeck, GermanyBrachytherapy; Radiotherapy; Head and neck cancer
